Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

116 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phenotype and immune function of lymph node and peripheral blood CLL cells are linked to transendothelial migration.
Pasikowska M, Walsby E, Apollonio B, Cuthill K, Phillips E, Coulter E, Longhi MS, Ma Y, Yallop D, Barber LD, Patten P, Fegan C, Ramsay AG, Pepper C, Devereux S, Buggins AG. Pasikowska M, et al. Among authors: patten p. Blood. 2016 Jul 28;128(4):563-73. doi: 10.1182/blood-2016-01-683128. Epub 2016 Jun 1. Blood. 2016. PMID: 27252234 Free article.
Venetoclax ramp-up strategies for chronic lymphocytic leukaemia in the United Kingdom: a real world multicentre retrospective study.
Figueroa-Mora R, Rampotas A, Halperin D, Worth T, Vidler J, Melotti D, Ferguson P, Elmusharaf N, Preston G, Furtado M, Dungarwalla M, Gohill S, Patten P, Kennedy B, Eyre TA, Schuh A, Fox CP, Munir T, Martinez-Calle N. Figueroa-Mora R, et al. Among authors: patten p. Br J Haematol. 2023 Jul;202(1):48-53. doi: 10.1111/bjh.18738. Epub 2023 Mar 23. Br J Haematol. 2023. PMID: 36951278
Tumor-derived IL-6 may contribute to the immunological defect in CLL.
Buggins AG, Patten PE, Richards J, Thomas NS, Mufti GJ, Devereux S. Buggins AG, et al. Among authors: patten pe. Leukemia. 2008 May;22(5):1084-7. doi: 10.1038/sj.leu.2405015. Epub 2007 Nov 1. Leukemia. 2008. PMID: 17972945 No abstract available.
Lymphoma diagnosis: an update.
Patten PE, Devereux S. Patten PE, et al. Clin Med (Lond). 2007 Dec;7(6):620-4. doi: 10.7861/clinmedicine.7-6-620. Clin Med (Lond). 2007. PMID: 18193715 Free PMC article. Review. No abstract available.
Outcome for patients with relapsed/refractory aggressive lymphoma treated with gemcitabine and oxaliplatin with or without rituximab; a retrospective, multicentre study.
Dhanapal V, Gunasekara M, Lianwea C, Marcus R, De Lord C, Bowcock S, Devereux S, Patten P, Yallop D, Wrench D, Fields P, Kassam S. Dhanapal V, et al. Among authors: patten p. Leuk Lymphoma. 2017 Sep;58(9):1-9. doi: 10.1080/10428194.2016.1276288. Epub 2017 Jan 16. Leuk Lymphoma. 2017. PMID: 28093003
116 results